Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angeles Alvarez Secord

Showing results (101-110 of 239) with videos related to

Pageof 24
Sort By:
Gynecologic Oncology|June 30, 2009
A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancerAngeles Alvarez Secord, Laura J Havrilesky, David M O'Malley, et al.
Gynecologic Oncology|January 13, 2006
Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histologyChristopher V Lutman, Laura J Havrilesky, Janiel M Cragun, et al.
Gynecologic Oncology|October 4, 2006
The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancerLaura J Havrilesky, Janiel M Cragun, Brian Calingaert, et al.
The American Journal of Surgical Pathology|December 13, 2012
BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomasKaruna Garg, Douglas A Levine, Narciso Olvera, et al.
Gynecologic Oncology Reports|October 2, 2015
Lumbee Native American ancestry and the incidence of aggressive histologic subtypes of endometrial cancerChelsea Zhang, Dario Roque, Jessie A Ehrisman, et al.
World Journal of Surgical Oncology|May 12, 2019
Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinomaAshley E Veade, Jonathan Foote, Jessie Ehrisman, et al.
Cancer|May 21, 2011
Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancerLaura J Havrilesky, Robin Pokrzywinski, Dennis Revicki, et al.
Gynecologic Oncology|March 20, 2012
Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancerRobin A Laskey, Marek S Poniewierski, Micael A Lopez, et al.
Gynecologic Oncology|May 31, 2021
The preferences of women with ovarian cancer for oral versus intravenous recurrence regimensLaura J Havrilesky, Amelia L Scott, Brittany A Davidson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 12, 2014
Obesity is associated with worse overall survival in women with low-grade papillary serous epithelial ovarian cancerRebecca Ann Previs, Joshua Kilgore, Renatta Craven, et al.
Pageof 24

Showing results (101-110 of 239) with videos related to

Sort By:
Pageof 24
Gynecologic Oncology|June 30, 2009
A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancerAngeles Alvarez Secord, Laura J Havrilesky, David M O'Malley, et al.
Gynecologic Oncology|January 13, 2006
Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histologyChristopher V Lutman, Laura J Havrilesky, Janiel M Cragun, et al.
Gynecologic Oncology|October 4, 2006
The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancerLaura J Havrilesky, Janiel M Cragun, Brian Calingaert, et al.
The American Journal of Surgical Pathology|December 13, 2012
BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomasKaruna Garg, Douglas A Levine, Narciso Olvera, et al.
Gynecologic Oncology Reports|October 2, 2015
Lumbee Native American ancestry and the incidence of aggressive histologic subtypes of endometrial cancerChelsea Zhang, Dario Roque, Jessie A Ehrisman, et al.
World Journal of Surgical Oncology|May 12, 2019
Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinomaAshley E Veade, Jonathan Foote, Jessie Ehrisman, et al.
Cancer|May 21, 2011
Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancerLaura J Havrilesky, Robin Pokrzywinski, Dennis Revicki, et al.
Gynecologic Oncology|March 20, 2012
Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancerRobin A Laskey, Marek S Poniewierski, Micael A Lopez, et al.
Gynecologic Oncology|May 31, 2021
The preferences of women with ovarian cancer for oral versus intravenous recurrence regimensLaura J Havrilesky, Amelia L Scott, Brittany A Davidson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 12, 2014
Obesity is associated with worse overall survival in women with low-grade papillary serous epithelial ovarian cancerRebecca Ann Previs, Joshua Kilgore, Renatta Craven, et al.
Pageof 24